File A03789 ("Requires science-based review for insurance denials") is before the New York Legislature and has not been decided. Latest step (February 10, 2026): amend by restoring to original print 3789.
New York file A03789, before the New York Legislature. Still to be decided as of 2026-02-10.
Faster access to prescribed drugs and treatments you need Insurance companies can no longer delay or deny your medications and medical services based on outdated or non-scientific criteria; they must now apply only evidence-based and peer-reviewed clinical standards when making coverage decisions.
Standardizes insurance review practices across treatment types Requiring uniform, science-based criteria for both drug formulary changes and pre-authorization decisions reduces inconsistency in which patients get coverage and encourages insurers to align decisions with current medical research rather than cost-cutting alone.
Implementation gaps may delay full effect of protections Agencies must define which clinical review criteria qualify as 'evidence-based and peer reviewed,' and disputes over that standard could create litigation or prolonged transitions where some insurers continue older review practices pending clarification.
Read the official record for A03789
See everything up for a vote · This week in New York · See what we have filed with the clerk